REVIEW PAPER
Role of surgical treatment for obesity in weight reduction and its effect on comorbidities
1
Uniwersytet Jana Kochanowskiego, Kielce, Polska
2
Zakład Żywienia i Dietetyki, Instytut Nauk o Zdrowiu, Collegium Medicum, Uniwersytet Jana Kochanowskiego, Kielce, Polska
Corresponding author
Monika Teresa Pierzak-Stępień
Uniwersytet Jana Kochanowskiego, al. IX Wieków Kielc 19a, 25-516 Kielce, Polska
Uniwersytet Jana Kochanowskiego, al. IX Wieków Kielc 19a, 25-516 Kielce, Polska
Med Og Nauk Zdr. 2024;30(1):7-13
KEYWORDS
obesitysleeve gastrectomygastric bypassbariatric/metabolic surgerylaparoscopic adjustable gastric bandingbiliopancreatic diversion/duodenal switch
TOPICS
ABSTRACT
Introduction and objective:
Obesity is a serious, complex and multifactorial disease affecting people worldwide. In just a few decades, it has become a huge public health problem for societies in different regions of the world. Bariatric surgery is the most effective method of treatment that allows for long- -term weight reduction and reduces the risk of developing comorbidities with obesity, and reduces the mortality rate. The aim of the study was evaluation of the role of surgical treatment for obesity in weight reduction and its effect on comorbidities.
Review methods:
Online scientific databases containing articles in Polish and English were systematically and comprehensively searched: systematic reviews, randomized control trials, meta-analyses, and clinical trials. The following scientific databases were searched: Pubmed, Web of Science, Google Scholar, Elsevier, and Scopus. The material was collected from April – September 2023. Article search was carried out by entering key words. Scientific articles covering the period from 2018–2023 constitute 54% of the items in the literature. During the search, case reports and published studies that appeared to contain significant methodological errors were excluded.
Brief description of the state of knowledge:
Considering the fact that more than 1,4 billion people worldwide are persons with overweight or obesity, it becomes justifiable to look for such therapeutic methods that are not only effective in reducing excess weight, but also in improving or complete remission of comorbidities
Summary:
Bariatric surgery is the most effective method of treatment that allows for long-term weight reduction, reducing the risk of developing comorbidities with obesity, and reducing the mortality rate.
Obesity is a serious, complex and multifactorial disease affecting people worldwide. In just a few decades, it has become a huge public health problem for societies in different regions of the world. Bariatric surgery is the most effective method of treatment that allows for long- -term weight reduction and reduces the risk of developing comorbidities with obesity, and reduces the mortality rate. The aim of the study was evaluation of the role of surgical treatment for obesity in weight reduction and its effect on comorbidities.
Review methods:
Online scientific databases containing articles in Polish and English were systematically and comprehensively searched: systematic reviews, randomized control trials, meta-analyses, and clinical trials. The following scientific databases were searched: Pubmed, Web of Science, Google Scholar, Elsevier, and Scopus. The material was collected from April – September 2023. Article search was carried out by entering key words. Scientific articles covering the period from 2018–2023 constitute 54% of the items in the literature. During the search, case reports and published studies that appeared to contain significant methodological errors were excluded.
Brief description of the state of knowledge:
Considering the fact that more than 1,4 billion people worldwide are persons with overweight or obesity, it becomes justifiable to look for such therapeutic methods that are not only effective in reducing excess weight, but also in improving or complete remission of comorbidities
Summary:
Bariatric surgery is the most effective method of treatment that allows for long-term weight reduction, reducing the risk of developing comorbidities with obesity, and reducing the mortality rate.
REFERENCES (36)
1.
Pierzak M, Głuszek S. The effect of weight reduction on the sexual function and reproductive health of obese men. Med Stud. 2022;38(3):233–244. https://doi.org/10.5114/ms.202....
2.
Apovian CM. Obesity: definition comorbidities, causes, and burden. AM J Mang Care. 2016;22(7):176–185. https://pubmed.ncbi.nlm.nih.go....
3.
Kim DS, Scherer PE. Obesity, Diabetes and Increased Cancer Progression. Diabetes Metab J. 2021;45(6):799–812. https://doi.org/10.4093/dmj.20....
5.
Safaei M, Sundararajan EA, Driss M, et al. A systematic review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity Comput Bio Med. 2021;136:104754. doi:10.1016/j.compbiomed.2021.104754.
6.
Young N, Atan IK, Rojas RG, et al. Obesity: how much does it matter for female pelvic organ prolapse? Int Urogynecol J. 2018;29(8):1129–1134. doi:10.1007/s00192-017-3455-8.
7.
Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol. (Lausanne) 2021:12;706978. doi:10.3389/fendo.2021.706978.
8.
Schutz DD, Busetto L, Dicker D, et al. European practical and patient centred guidelines for adult obesity management in primary care. Obes Facts. 2019;12(1):40–66. doi:https://doi.org/10.1159/000496....
9.
Blüher M. Metabolically Healthy Obesity. Endocrine Rev. 2020;41(3):1–16. https://doi.org/10.1210/endrev....
10.
Aaseth J, Ellefsen S, Alehagen U, et al. Diets and drugs for weight loss and health in obesity – An update. Biomed Pharmacother. 2021;140:111789. https://doi.org/10.1016/j.biop....
11.
Ruban A, Stoenchev K, Ashrafian H, et al. Current treatments for obesity. Cli Med. 2019;19(3): 205–212. https://doi.org/10.7861/clinme....
12.
Mehta A, Shariaiha RZ. Bariatric and metabolic endoscopy: impact on obesity and related comorbidities. Ther Adv Gastrointest Endosc. 2021;14:1–8. https://doi.org/10.1177/263177....
13.
Kheniser KG and Kashyap SR. Diabetes management before, during, and after bariatric and metabolic surgery. J Diabetes Complications. 2018;32(9):870–875. https://doi.org/10.1016/j.jdia....
14.
Alqahtani A, Al-Darwish A, Mahmoud AE, et al. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019;89(6):1132–1138. https://doi.org/10.1016/j.gie.....
15.
Fink J, Seifert G, Blüher M, et al. Obesity Surgery: Weight Loss, Metabolic Changes, Oncological Effects, and Follow-Up. Dtsch Arztebl Int. 2022;119:70–80. https://doi.org/10.3238/arzteb....
16.
Budzyński A, Major P, Głuszek S, et al. Polskie rekomendacje w zakresie chirurgii bariatrycznej i metabolicznej. Med Prakt Chirurgia. 2016;6:13–26. https://wssk.wroc.pl/files/upl... (access: 18.12.23).
17.
Sjöström L, Narbro K, Sjöström D, et al. Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects. N Engl J Med. 2007;23(8):741–752. https://doi.org/10.1056/NEJMoa....
18.
Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after Roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis. 2016;12(1):11–20. https://doi.org/10.1016/j.soar....
19.
Topart P, Becouarn G, Salle A. Five-year follow-up after biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2011;7(2):199–205. https://doi.org/10.1016/j.soar....
20.
O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33. https://doi.org/10.7326/0003-4....
21.
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA 2018;319(3):255–265. https://doi.org/ 10.1001/jama.2017.20897.
22.
Dixon JB, Schachter LM, O’Brien PE, et al. Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlledtrial. JAMA. 2012;308(11):1142–9. https://doi.org/ 10.1001/2012.jama.11580.
23.
Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347. https://doi.org/10.1136/bmj.f5....
24.
Chang SH, Stoll CRT, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–287. https://doi.org/doi:10.1001/ja....
25.
Courcoulas AP, Gallagher JW, Neiberg RH, et al. Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial. J Clin Endocrinol Metab. 2020;105(3):866–876. https://doi.org/doi:10.1210./c....
26.
Uhe I, Douissar J, Podetta M, et al. Roux-en-Y gastric bypass, sleeve gastrectomy, or one-anastomosis gastric bypass? A systematic review and meta-analysis of randomized-controlled trials. Obesity. 2022;30(3):614–627. https://doi.org/10.1002/oby.23....
27.
Li JF, Lai DD, Lin ZH, et al. Comparison of the long-term results of Roux-en-Y gastric bypass and sleeve gastrectomy for morbid obesity: a systematic review and metaanalysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutan Tech. 2014;24(1):1–11. https://doi.org/10.1097/SLE.00....
28.
Benaiges D, Más-Lorenzo A, Goday A, et al. Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure? World J Gastroenterol. 2015;21(41):11804–11814. https://doi.org/10.3748/wjg.v2....
29.
Han J, Jia Y, Wang H, et al. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies. Int J Surg. 2020;76:101–110. https://doi.org/10.1016/j.ijsu....
30.
Gill RS, Lai M, Birch DW, et al. Sleeve Gastrectomy: Procedure, Outcomes, and Complications. 2012;1:75–79. https://doi.org/10.1007/s13679....
31.
Cottam D, Qureshi FG, Matter SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20(6):859–863. https://doi.org/10.1007/s00464....
32.
Colquitt JL Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014;8:CD003641. https://doi.org/10.1002/146518....
33.
Pucci A, Batterham RL. Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. J Endocrinol Invest. 2019;42(2):117–128. https://doi.org/10.1007/s40618....
34.
Ribaric G, Buchwald J. Gastric band is safe and effective at three years in a national study subgroup of non-morbidly obese patients. Croat Med J. 2014;28:405–15. https://doi.org/10.3325/cmj.20....
35.
Strain WG, Torghabeh MH, Gagner M, et al. The Impact of Biliopancreatic Diversion with Duodenal Switch (BPD/DS) Over 9 Years. Obes Surg. 2017;27(3):787–794. https://doi.org/10.1007/s11695....
36.
Pierzak-Stępień M. Available therapies for the treatment of obesity. Are lifestyle modifications and pharmacotherapy enough to reduce weight? – review of the literature. J Educ Health Sport. 2023;44(1):128–155. https://doi.org/10.12775/JEHS.....
Share
RELATED ARTICLE
| eISSN: | 2084-4905 |
| ISSN: | 2083-4543 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
